Preferred Name

dihydropteridine reductase deficiency

Synonyms

hyperphenylalaninemia, BH4-deficient C

disorder of 6,7-dihydropteridine reductase activity

phenylketonuria type 2

hyperphenylalaninemia, Bh4-deficient, type C

PKU type 2

6,7-dihydropteridine reductase activity disease

hyperphenylalaninemia due to dihydropteridine reductase deficiency

dihydropteridine reductase deficiency

quinoid dihydropteridine reductase deficiency

DHPR deficiency

Qdpr deficiency

hyperphenylalaninemia, BH-4-deficient, C

hyperphenylalaninemia, tetrahydrobiopterin-deficient, due to DHPR deficiency

hyperphenylalaninemia, BH4-deficient, C

HPABH4C

Definitions

Dihydropteridine reductase (DHPR) deficiency is a severe form of hyperphenylalaninemia (HPA) due to impaired regeneration of tetrahydrobiopterin (BH4), leading to decreased levels of neurotransmitters (dopamine, serotonin) and folate in cerebrospinal fluid, and causing neurological symptoms such as psychomotor delay, hypotonia, seizures, abnormal movements, hypersalivation, and swallowing difficulties.

ID

http://purl.obolibrary.org/obo/MONDO_0009862

has_exact_synonym

hyperphenylalaninemia, BH4-deficient C

disorder of 6,7-dihydropteridine reductase activity

phenylketonuria type 2

hyperphenylalaninemia, Bh4-deficient, type C

PKU type 2

6,7-dihydropteridine reductase activity disease

hyperphenylalaninemia due to dihydropteridine reductase deficiency

dihydropteridine reductase deficiency

has_related_synonym

quinoid dihydropteridine reductase deficiency

DHPR deficiency

Qdpr deficiency

hyperphenylalaninemia, BH-4-deficient, C

hyperphenylalaninemia, tetrahydrobiopterin-deficient, due to DHPR deficiency

hyperphenylalaninemia, BH4-deficient, C

HPABH4C

label

dihydropteridine reductase deficiency

prefixIRI

MONDO:0009862

prefLabel

dihydropteridine reductase deficiency

seeAlso

https://rarediseases.info.nih.gov/diseases/4319/dihydropteridine-reductase-deficiency

textual definition

Dihydropteridine reductase (DHPR) deficiency is a severe form of hyperphenylalaninemia (HPA) due to impaired regeneration of tetrahydrobiopterin (BH4), leading to decreased levels of neurotransmitters (dopamine, serotonin) and folate in cerebrospinal fluid, and causing neurological symptoms such as psychomotor delay, hypotonia, seizures, abnormal movements, hypersalivation, and swallowing difficulties.

subClassOf

http://purl.obolibrary.org/obo/MONDO_0016543

http://purl.obolibrary.org/obo/MONDO_0045014

Delete Subject Author Type Created
No notes to display